John Wiley & Sons, Inc., today announced the launch of Molecular
Genetics & Genomic Medicine (MGGM), a new Wiley
Open Access journal. Under the leadership of Editor-in-Chief Dr.
Maximilian Muenke, the journal will provide rapid dissemination of
high-quality research in all areas of human, medical and molecular
genetics.
Dr. Muenke, a renowned medical geneticist, trained in pediatrics in his
native Germany and then pursued postdoctoral fellowship training in
human and clinical genetics at Yale and the University of Pennsylvania.
He is now based at a leading research organization in Bethesda, USA.
Dr. Muenke’s group identified several genes important in craniofacial
disorders including one of the most common, now termed Muenke syndrome.
More recently, his lab has identified susceptibility genes for the most
common childhood behavioral disorder, Attention-Deficit/Hyperactivity
Disorder (ADHD), with further research focused on predicting severity,
treatment, and long-term outcome.
Working alongside an international editorial board of experts in diverse
areas of human and medical genetics and genomics, Dr. Muenke will
oversee the rigorous peer-review and evaluation of articles submitted
for publication in MGGM.
“I am extremely excited about being the founding editor of this new
journal,” says Dr. Muenke. “Since there is not a single disorder that
does not have a genetic origin, I believe that the fields of molecular
genetics and genomic medicine will be expanding into virtually all
medical specialties. MGGM will grow as well, with articles on diseases
from diagnosis to treatment, as a step toward personalized medicine. ”
Molecular Genetics & Genomic Medicine is the latest addition
to Wiley’s portfolio of genetics journals and will benefit from
relationships with widely respected titles including the American
Journal of Medical Genetics and Human
Mutation.
“We’re delighted to expand our open access portfolio with the addition
of this important new journal,” said Rachel Burley, Vice President and
Director, Open Access, Wiley. “Under the expert editorial leadership of
Dr. Muenke, Molecular Genetics & Genomic Medicine will
make a valuable contribution to the literature.”
The journal is open to submissions now and will publish online in spring
2013. Please visit the journal’s websitewww.MGGMjournal.com for
further information and future updates.
